Welcome to our dedicated page for Abacus Global Management news (Ticker: ABX), a resource for investors and traders seeking the latest updates and insights on Abacus Global Management stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Abacus Global Management's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Abacus Global Management's position in the market.
Abacus Global Management (NYSE: ABX) published a shareholder letter outlining record 2025 momentum and a shift toward recurring fee revenue. Key disclosed metrics include Q3 revenue +124% YoY, adjusted net income +60% YoY, adjusted EBITDA +127% with 60% margins, and raised full‑year adjusted net income guidance to $80–$84 million (up 72%–81% YoY). Assets under management grew to $3.33 billion. The company completed a $50 million investment‑grade securitized note backed by life insurance assets while retaining servicing rights, launched an asset‑based finance strategy for 2026, acquired AccuQuote, and initiated a $0.20 annual dividend plus a 10 million share repurchase program. Abacus debuted on the NYSE under symbol ABX on December 30.
Abacus Global Management (NYSE: ABX) announced on January 6, 2026 the launch of an asset-based finance (ABF) strategy within Abacus Asset Group led by Monty Cook and Elena Plesco.
The strategy targets a broad set of asset-backed investments—consumer credit, equipment finance, receivables, small business loans, IP rights, and insurance-centric assets—aiming for net risk-adjusted returns of 11–13% and a target average investment duration of 3–5 years. It intends approximately 65% of allocations to holdings with investment grade-like characteristics and leverages Abacus's proprietary insurance analytics and actuarial models to support origination, underwriting, and portfolio monitoring. Management cites a $20 trillion+ market opportunity and plans to serve institutional clients, especially insurance carriers.
FAQ
What is the current stock price of Abacus Global Management (ABX)?
What is the market cap of Abacus Global Management (ABX)?
